New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 31, 2013
08:48 EDTQGENQIAGEN price target raised to $26 from $20 at RW Baird
Baird raised its price target on QIAGEN following better than expected Q4 results. The firm cited higher guidance, tangible drivers of organic growth, and cash available for accretive use. Shares are Outperform rated.
News For QGEN From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
December 18, 2014
06:21 EDTQGENQIAGEN downgraded to Sell from Neutral at Goldman
Goldman downgraded QIAGEN to Sell based on a mixed growth outlook for new products and the dilutive impact on the core franchise value from M&A. Price target lowered to $19 from $21.
December 4, 2014
16:03 EDTQGENQIAGEN to distribute altona Diagnostics RealStar Ebolavirus kit
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use